By Benjamin Flowers: The World Health Organization (WHO) has announced its recommendation for two new drugs designed to treat COVID-19, Yahoo News reports.
The WHO made its announcement on Friday, that it is strongly recommending the use of baricitinib, an oral drug typically used to treat rheumatoid arthritis, for patients who have severe COVId-19 symptoms.
The WHO is also recommending the use of sotrovimab, a monoclonal antibody drug, to treat mild or moderate symptoms in patients at high risk of hospitalization, including patients who are older, immunocompromised, and unvaccinated.
“The extent to which these medicines will save lives depends on how widely available and affordable they will be,” the WHO said.
The WHO recommended using the two drugs following a review of seven trials involving over 4,000 patients. Those patients had exhibited a wide range of COVId-19 symptoms. The wHO also said that it was working to ensure that there would be equitable and sustainable global access to the newly recommended treatments.